Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia

por Liberante, Fabio Giuseppe, Pouryahya, Tara, McMullin, Mary-Frances, Zhang, Shu-Dong, Mills, Kenneth Ian
Publicado 2015